InfuSystem Holdings (INFU) Given Daily News Sentiment Rating of 0.10
News coverage about InfuSystem Holdings (NYSE:INFU) has trended somewhat positive on Monday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. InfuSystem Holdings earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave media headlines about the medical instruments supplier an impact score of 47.6171181420797 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Edited Transcript of INFU earnings conference call or presentation 9-Aug-17 8:30pm GMT (finance.yahoo.com)
- InfuSystem Holdings Inc (INFU) Releases Earnings Results (americanbankingnews.com)
- InfuSystem Holdings, Inc. Reports Second Quarter 2017 Financial Results (finance.yahoo.com)
- Applied Materials, Inc. (NASDAQ:AMAT) Position Increased by Capital Investment Advisors LLC (overnewsmagazine.com)
Shares of InfuSystem Holdings (NYSE INFU) traded up 2.63% during trading on Monday, hitting $1.95. 117,741 shares of the stock were exchanged. The stock’s market cap is $44.37 million. InfuSystem Holdings has a 12-month low of $1.20 and a 12-month high of $3.04. The stock has a 50-day moving average of $1.78 and a 200 day moving average of $1.96.
InfuSystem Holdings (NYSE:INFU) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported ($0.02) earnings per share for the quarter. InfuSystem Holdings had a negative return on equity of 11.82% and a negative net margin of 8.37%. The company had revenue of $16.94 million during the quarter. Equities analysts predict that InfuSystem Holdings will post $0.24 earnings per share for the current fiscal year.
In other InfuSystem Holdings news, Director Ryan J. Morris purchased 29,614 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was bought at an average cost of $1.45 per share, with a total value of $42,940.30. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders acquired a total of 70,928 shares of company stock valued at $102,927 over the last three months.
ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/infusystem-holdings-infu-given-daily-news-sentiment-rating-of-0-10/1487790.html.
About InfuSystem Holdings
InfuSystem Holdings, Inc is a provider of infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers and other sites of care. The Company delivers local, field-based customer support and also operates pump service and repair Centers of Excellence in Michigan, Kansas, California, Texas and Ontario, Canada.
Receive News & Ratings for InfuSystem Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.